Tweaking the glucose sensor: Adjusting glucokinase activity with activator compounds

Endocrinology

Volumn 146, Issue 9, 2005, Pages 3693-3695

  Printz, Richard L ^a   Granner, Daryl K ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYCLOHEXYL 1 (4 METHANESULFONYLPHENYL)CYCLOPROPANECARBOXYLIC ACID 2 THIAZOLYLAMIDE; ANTIDIABETIC AGENT; GLUCOKINASE; GLUCOKINASE ACTIVATOR; GLUCOSE; HORMONES AND AGENTS ACTING ON THE ENDOCRINE SYSTEM; INSULIN; UNCLASSIFIED DRUG;

DRUG CLASSIFICATION; ENZYME ACTIVITY; GENE MUTATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PRIORITY JOURNAL; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATORS; GLUCOKINASE; HUMANS;

EID: 23844478345     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2005-0689     Document Type: Short Survey

References (25)

1. Stumvoll M, Goldstein BJ, van Haeften TW 2005 Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365:1333-1346
2. Basu R, Basu A, Johnson CM, Schwenk WF, Rizza RA 2004 Insulin doseresponse curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes. Diabetes 53:2042-2050
3. Moller DE 2001 New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414:821-827
4. Zelent D, Najafi H, Odili S, Buettger C, Weik-Collins H, Li C, Doliba N, Grimsby J, Matschinsky FM 2005 Glucokinase and glucose homeostasis: proven concepts and new ideas. Biochem Soc Trans 33:306-310
5. Matschinsky FM 2002 Regulation of pancreatic β-cell glucokinase: from basics to therapeutics. Diabetes 51(Suppl 3):S394-S404
6. Magnuson MA, Matschinsky FM 2004 Glucokinase and glycemic disease: from basics to novel therapeutics. Basel: Karger
7. Matschinsky FM 2005 Glucokinase, glucose homeostasis, and diabetes mellitus. Curr Diab Rep 5:171-176
8. McKerrecher D, Allen JV, Bowker SS, Boyd S, Caulkett PW, Currie GS, Davies CD, Fenwick ML, Gaskin H, Grange E, Hargreaves RB, Hayter BR, James R, Johnson KM, Johnstone C, Jones CD, Lackie S, Rayner JW, Walker RP 2005 Discovery, synthesis and biological evaluation of novel glucokinase activators. Bioorg Med Chem Lett 15:2103-2106
9. Castelhano AL, Dong H, Fyfe MC, Gardner LS, Kamikozawa Y, Kurabayashi S, Nawano M, Ohashi R, Procter MJ, Qiu L, Rasamison CM, Schofield KL, Shah VK, Ueta K, Williams GM, Witter D, Yasuda K 2005 Glucokinase-activating ureas. Bioorg Med Chem Lett 15:1501-1504
10. Kamata K, Mitsuya M, Nishimura T, Eiki J, Nagata Y 2004 Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. Structure (Camb) 12:429-438
11. Brocklehurst KJ, Payne VA, Davies RA, Carroll D, Vertigan HL, Wightman HJ, Aiston S, Waddell ID, Leighton B, Coghlan MP, Agius L 2004 Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators. Diabetes 53:535-541
12. Grimsby J, Sarabu R, Corbett WL, Haynes NE, Bizzarro FT, Coffey JW, Guertin KR, Hilliard DW, Kester RF, Mahaney PE, Marcus L, Qi L, Spence CL, Tengi J, Magnuson MA, Chu CA, Dvorozniak MT, Matschinsky FM, Grippo JF 2003 Allosteric activators of glucokinase: potential role in diabetes therapy. Science 301:370-373
13. Efanov AM, Barrett DG, Brenner MB, Briggs SL, Delaunois A, Durbin JD, Giese U, Guo H, Radloff M, Sanz Gil G, Sewing S, Wang Y, Weichert A, Zaliani A, Gromada J 2005 A novel glucokinase activator modulates pancreatic islet and hepatocyte function. Endocrinology 146:3696-3701
14. Gloyn AL 2003 Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum Mutat 22:353-362
15. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckmann JS, Bell GI, Cohen D 1993 Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 328:697-702
16. Porter JR, Shaw NJ, Barrett TG, Hattersley AT, Ellard S, Gloyn AL 2005 Permanent neonatal diabetes in an Asian infant. J Pediatr 146:131-133
17. Njolstad PR, Sovik O, Cuesta-Munoz A, Bjorkhaug L, Massa O, Barbetti F, Undlien DE, Shiota C, Magnuson MA, Molven A, Matschinsky FM, Bell GI 2001 Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344:1588-1592
18. Gloyn AL, Noordam K, Willemsen MA, Ellard S, Lam WW, Campbell IW, Midgley P, Shiota C, Buettger C, Magnuson MA, Matschinsky FM, Hattersley AT 2003 Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. Diabetes 52:2433-2440
19. Christesen HB, Jacobsen BB, Odili S, Buettger C, Cuesta-Munoz A, Hansen T, Brusgaard K, Massa O, Magnuson MA, Shiota C, Matschinsky FM, Barbetti F 2002 The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy. Diabetes 51:1240-1246
20. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, Stanley CA, Thornton PS, Permutt MA, Matschinsky FM, Herold KC 1998 Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 338:226-230
21. Inoue M, Sakuraba Y, Motegi H, Kubota N, Toki H, Matsui J, Toyoda Y, Miwa I, Terauchi Y, Kadowaki T, Shigeyama Y, Kasuga M, Adachi T, Fujimoto N, Matsumoto R, Tsuchihashi K, Kagami T, Inoue A, Kaneda H, Ishijima J, Masuya H, Suzuki T, Wakana S, Gondo Y, Minowa O, Shiroishi T, Noda T 2004 A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program. Hum Mol Genet 13:1147-1157
22. Gloyn AL, Odili S, Zelent D, Buettger C, Castleden HA, Steele AM, Stride A, Shiota C, Magnuson MA, Lorini R, d'Annunzio G, Stanley CA, Kwagh J, van Schaftingen E, Veiga-da-Cunha M, Barbetti F, Dunten P, Han Y, Grimsby J, Taub R, Ellard S, Hattersley AT, Matschinsky FM 2005 Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. J Biol Chem 280:14105-14113
23. Agius L, Peak M, Newgard CB, Gomez-Foix AM, Guinovart JJ 1996 Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis. J Biol Chem 271:30479-30486
24. Van Schaftingen E 1989 A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6-phosphate and fructose 1-phosphate. Eur J Biochem 179:179-184
25. Chu CA, Fujimoto Y, Igawa K, Grimsby J, Grippo JF, Magnuson MA, Cherrington AD, Shiota M 2004 Rapid translocation of hepatic glucokinase in response to intraduodenal glucose infusion and changes in plasma glucose and insulin in conscious rats. Am J Physiol Gastrointest Liver Physiol 286:G627-G634